Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (Q34066078)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel |
scientific article |
Statements
1 reference
Circulating miR-19a and miR-205 in serum may predict the sensitivity of luminal A subtype of breast cancer patients to neoadjuvant chemotherapy with epirubicin plus paclitaxel (English)
1 reference
Qian Li
1 reference
Mei Liu
1 reference
Fei Ma
1 reference
Yang Luo
1 reference
Ruigang Cai
1 reference
Liming Wang
1 reference
Ningzhi Xu
1 reference
Binghe Xu
1 reference
19 August 2014
1 reference
1 reference
e104870
1 reference
19 August 2014
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference